Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

820
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
820
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

2.5K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
2.5K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The National Practice Benchmark for Oncology, 2013 Report on 2012 Data.

Journal of oncology practice·2018
Same author

The National Practice Benchmark for oncology, 2014 report on 2013 data.

Journal of oncology practice·2014
Same author

National Oncology Practice Benchmark, 2012 report on 2011 data.

Journal of oncology practice·2013
See all related articles

Related Experiment Video

Updated: Mar 23, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

846

The National Practice Benchmark for Oncology: 2015 Report for 2014 Data.

Carla Balch1, John D Ogle1, James L Senese2

  • 1NantCare; Ogle Clinton, Memphis, TN; and Flatiron Health, New York, NY.

Journal of Oncology Practice
|March 24, 2016
PubMed
Summary
This summary is machine-generated.

The National Practice Benchmark (NPB) offers a standardized method for oncology practices to assess their performance against national standards. This tool aids in analyzing business practices for strategic improvements in a competitive healthcare market.

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

5.9K

Related Experiment Videos

Last Updated: Mar 23, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

846
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

5.9K

Area of Science:

  • Health Services Research
  • Health Economics
  • Oncology Practice Management

Background:

  • The current economic climate necessitates that oncology practices differentiate themselves to attract patients.
  • Understanding practice performance relative to peers is crucial for strategic positioning.
  • Existing benchmarks may not adequately account for variations in practice demographics, size, and setting.

Purpose of the Study:

  • To introduce the refined National Practice Benchmark (NPB) as a tool for evaluating oncology practices.
  • To provide a meaningful comparison of oncology practices across diverse settings.
  • To support data-driven decision-making in oncology practice management.

Main Methods:

  • Building upon data collection methodologies from Oncology Metrics.
  • Refining definitions to enhance the relevance and accuracy of benchmark metrics.
  • Analyzing data from community oncology practices, reflecting business structures and healthcare system arrangements.

Main Results:

  • The NPB provides detailed metrics enabling practices to measure and analyze current business operations.
  • The benchmark report reflects the business structure and integration with regional healthcare systems.
  • The NPB offers a uniquely meaningful comparison within the oncology market.

Conclusions:

  • The National Practice Benchmark (NPB) is a valuable tool for oncology practices to assess and improve their business and clinical management.
  • Utilizing NPB metrics can lead to data-informed strategic adjustments for enhanced practice performance.
  • The refined NPB provides a robust framework for benchmarking in the evolving oncology landscape.